Skip to main content
. 2017 Sep 22;17:638. doi: 10.1186/s12879-017-2745-6

Table 3.

Details of 9 patients with low albumin and high CRP

No. Age Primary disease Stem cell source Conditioning Duration from transplantation to infection (days) Engraftment CRP (mg/dl) Albumin (g/dl) Severe sepsis or septic shock Initial source of infection Subsequent progression to pneumonia (days) Treatment Survival (days)
1 32 AML uBM BU+CY+TLI 124 Yes 11.6 1.9 - Sources unknown Yes (1) MINO 12
2 58 AML CB Flu+Mel+TBI 26 No 14.4 2.3 Severe Pneumonia - 2
3 54 AML CB CA+CY+TBI 15 Yes 18.5 2.5 Severe Sources unknown Yes (5) MINO 7
4 70 CMLBC CB Flu+Mel+TBI 20 No 40.8 2.9 Severe Pneumonia CPFX 2
5 69 AML uBM Flu+Mel+TBI 11 Yes 19.8 2.6 Shock Pneumonia - 2
6 64 PMF uBM Flu+Mel+TBI 34 No 25.3 1.6 Severe Pneumonia CPFX 2
7 57 FL uPB Flu+CY+TBI 10 No 15.9 2.4 Shock Sources unknown Yes (8) CPFX+MINO 10
8 30 AML uBM CY+TBI 373 Yes 23 1.6 Shock CLABSI Yes (1) CPFX+MINO→ST+MINO 2
9 56 AML uBM Flu+BU+TBI 17 No 17.8 1.6 Severe Pneumonia and cellulitis TGC→ST+TGC 32

Abbreviations: AML acute myeloid leukemia, CMLBC chronic myeloid leukemia blast crisis, PMF primary myelofibrosis, FL follicular lymphoma, uBM unrelated-bone marrow, CB cord blood, uPB unrelated-peripheral blood, BU busulfan, CY cyclophosphamide, TLI total lymphoid irradiation, Flu fludarabine, Mel melphalan, TBI total body irradiation, CRP c-reactive protein, CLABSI central-line associated blood stream infection, MINO minocycline, CPFX ciprofloxacin, ST trimethoprim-sulfamethoxazole, TGC tigecycline